{
  "id": 14748502,
  "title": "Stock Split Watch: Is Eli Lilly Next?",
  "url": "https://urgent.news/2026/10/15/stock-split-watch-is-eli-lilly-next",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-15T17:10:01.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/10/15/stock-split-watch-is-eli-lilly-next/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "Eli Lilly (LLY), a pharmaceutical firm, has seen its stock soar over 300% in the past five years, reaching levels above $1,200. This has sparked speculation about a potential stock split. Stock splits involve issuing additional shares to existing shareholders, which lowers each share's price proportionally. This makes the stock more accessible to a wider range of investors and can make it seem less expensive. Eli Lilly has a history of stock splits, having conducted four in the past, though the last one was nearly three decades ago. Currently, the company's stock is trading at $1,160, and recent momentum, driven by the launch of a new weight loss drug GLP-1 pill Foundayo, could signal a future split. However, it's crucial to note that stock splits don't fundamentally alter a company's value or performance.",
  "summary": "The stock has soared 25% in six months.",
  "key_points": [
    "Eli Lilly's stock has surged over 300% in five years.",
    "Company has split shares four times previously.",
    "Recent GLP-1 drug launch may trigger next split."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Stock Split Watch: Is Eli Lilly Next?",
        "url": "https://urgent.news/2026/10/15/stock-split-watch-is-eli-lilly-next-14757055",
        "published": "2026-10-15T17:30:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}